REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 24th, 2020 • Akers Biosciences, Inc. • In vitro & in vivo diagnostic substances • New York
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 23, 2020 (the “Execution Date”), is entered into by and between Akers Biosciences, Inc., a New Jersey corporation (the “Company”), and the undersigned members (each, individually, a “Seller,” and collectively, “Sellers”) of Cystron Biotech, LLC, a Delaware limited liability company (“Cystron”), identified on the signature pages to that certain Membership Interest Purchase Agreement, by and between the parties hereto, dated as of the Execution Date (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement.
SHAREHOLDER VOTING AGREEMENTShareholder Voting Agreement • March 24th, 2020 • Akers Biosciences, Inc. • In vitro & in vivo diagnostic substances • New York
THIS SHAREHOLDER VOTING AGREEMENT (this “Agreement”) is made and entered into as of March 23, 2020, by and among Akers Biosciences, Inc. (the “Company”) and each of the undersigned Stockholders of the Company (the “Stockholders”).
AMENDED & RESTATED LICENSE AND DEVELOPMENT AGREEMENTLicense and Development Agreement • March 24th, 2020 • Akers Biosciences, Inc. • In vitro & in vivo diagnostic substances • New York
THIS LICENSE AND DEVELOPMENT AGREEMENT (“Agreement”), effective as of March 19, 2020 (the “Effective Date”), is intended to replace the agreement of the same name entered March 10, 2020 (the “Original Effective Date”), and is similarly made by and between PREMAS BIOTECH PVT LTD a corporation organized and existing under the laws of India (“Premas”), and CYSTRON BIOTECH, LLC, a limited liability company organized and existing under the laws of the State of Delaware (“Licensee”).
Membership Interest Purchase AgreementMembership Interest Purchase Agreement • March 24th, 2020 • Akers Biosciences, Inc. • In vitro & in vivo diagnostic substances • New York
This Membership Interest Purchase Agreement (this “Agreement”), dated as of March 23, 2020 (the “Effective Date”), is entered into between the members of Cystron Biotech, LLC, a Delaware limited liability company, identified on the signature pages hereto (each, individually, a “Seller,” and collectively, “Sellers”), and Akers Biosciences, Inc., a New Jersey corporation (“Buyer” or “Akers”).
